These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 2894653
1. Treatment of cardiac myopathies with beta blockers. What do we know, where do we go from here? Anderson JL. Postgrad Med; 1988 Feb 29; Spec No():104-12. PubMed ID: 2894653 [Abstract] [Full Text] [Related]
5. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment. Braun M, Edelmann F, Knapp M, Schön S, Schwencke C, Simonis G, Borst M, Weinbrenner C, Strasser RH. Int J Cardiol; 2009 Feb 20; 132(2):248-56. PubMed ID: 18579230 [Abstract] [Full Text] [Related]
6. [Safety and tolerability of beta-blockers in severe cardiac decompensation from dilated cardiomyopathy]. Sinagra G, Perkan A, Zecchin M, Di Lenarda A, Lardieri G, Rakar S, Secoli G, Pinamonti B, Camerini F. G Ital Cardiol; 1995 Oct 20; 25(10):1255-63. PubMed ID: 8682221 [Abstract] [Full Text] [Related]
7. [How and to what extent has beta-blocker treatment been established for chronic heart failure?]. Yokota Y. J Cardiol; 1996 Aug 20; 28(2):99-112. PubMed ID: 8814528 [Abstract] [Full Text] [Related]
13. [Adrenergic betablockers and heart failure]. Lechat P. Arch Mal Coeur Vaiss; 1995 Apr 20; 88(4 Suppl):611-5. PubMed ID: 7487311 [Abstract] [Full Text] [Related]
14. [Critical analysis of beta blockers in heart failure: certainty and incompleteness]. Rapezzi C, Branzi A. Ital Heart J Suppl; 2000 Aug 20; 1(8):1003-10. PubMed ID: 10993006 [Abstract] [Full Text] [Related]
15. Use of beta-blockers in chronic congestive heart failure. Mahanonda N, Samranthin M, Panyarachun S. J Med Assoc Thai; 2000 Oct 20; 83(10):1240-7. PubMed ID: 11143491 [Abstract] [Full Text] [Related]
16. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome. De Maria R, Di Lenarda A, Gavazzi A, Porcu M, Sinagra G, Parolini M, SPIC (Italian Multicenter Cardiomyopathy Study) Group. Ital Heart J; 2001 Feb 20; 2(2):130-8. PubMed ID: 11256541 [Abstract] [Full Text] [Related]
17. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Am Heart J; 2001 Apr 20; 141(4):645-52. PubMed ID: 11275933 [Abstract] [Full Text] [Related]
18. Beta-blockade in adriamycin-induced cardiomyopathy. Noori A, Lindenfeld J, Wolfel E, Ferguson D, Bristow MR, Lowes BD. J Card Fail; 2000 Jun 20; 6(2):115-9. PubMed ID: 10908085 [Abstract] [Full Text] [Related]
19. Therapeutic effect of {beta}-adrenoceptor blockers using a mouse model of dilated cardiomyopathy with a troponin mutation. Zhan DY, Morimoto S, Du CK, Wang YY, Lu QW, Tanaka A, Ide T, Miwa Y, Takahashi-Yanaga F, Sasaguri T. Cardiovasc Res; 2009 Oct 01; 84(1):64-71. PubMed ID: 19477965 [Abstract] [Full Text] [Related]
20. [Prognosis of hypertrophic and dilated cardiomyopathy]. Ikeda H, Imaizumi T. Nihon Rinsho; 2000 Jan 01; 58(1):86-92. PubMed ID: 10885294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]